Fox Chase Researchers Examine Role of Pembrolizumab in Treating Patients With Metastatic Neuroendocrine Tumors
PHILADELPHIA (May 11, 2020) — Combination strategies targeting the immune checkpoint pathway from multiple angles may be the key. A recent study suggested the benefit of two immune checkpoint drugs, which showed promising response in this rare cancer.